Volver a Agenda
Session Chair(s)
Christopher Marrone, PHARMD, RPH
Outcomes Liaison Advisor – National Accounts, Value, Evidence and Outcomes (VEO)
Eli Lilly and Company, United States
Learning Objective : Define evidence-based medicine; Explain the shift towards comparative effectiveness research; Discuss the key ethical, socio-political, and commercial implications of this shift.
Speaker(s)
Panelist
Wendy Louise Lipworth
University of Sydney, Australia
Senior Research Fellow, Centre for Values, Ethics and the Law in Medicine
Panelist
Kitty Rajagopalan, PHD, MS
Sunovion Pharmaceuticals Inc., United States
Vice President, Health Economics and Outcomes Research
Panelist
Lisa M. Hess, PHD
Eli Lilly and Company, United States
Principal Research Scientist, US Health Outcomes
¿Tiene una cuenta?